Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg(Fistulacure), Sharad S. Singhal(City Of Hope National Medical Center), Ravi Salgia(City Of Hope National Medical Center), Jyoti Malhotra(City Of Hope National Medical Center), Prakash Kulkarni(University of Maryland, Baltimore), David Horne(City Of Hope National Medical Center)
Cited by 268
Related Papers
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
|Journal for ImmunoTherapy of Cancer|2018|1.3k
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
|Journal of Clinical Oncology|2011|551
c-Met Overexpression Is a Prognostic Factor in Ovarian Cancer and an Effective Target for Inhibition of Peritoneal Dissemination and Invasion
|Cancer Research|2007|260
Arithmetic of vulnerable plaques for noninvasive imaging
|Nature Clinical Practice Cardiovascular Medicine|2008|165
c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma
|Clinical Cancer Research|2007|154